Topic: The Lancet
HONG KONG (Reuters) - Two antidepressants that are commonly given to Alzheimer's disease patients appear not only to be ineffective but may give side effects such as nausea and drowsiness, a study in Britain has found.In a paper published in the medical ...
An early study has shown that the new drug PBT2 improves two indicators of executive function in patients with Alzheimer's disease (AD), and reduces the levels of the Alzheimer's-associated protein amyloid in the spinal fluid in these patients. These are the conclusions ...
